{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-025884","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.419984+00:00","generated_at":"2026-05-31T23:45:51.092141+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Processa shareholders elect directors, approve equity plan increase and auditor ratification","bullets":["All six director nominees (Yorke, Ng, Baluch, Neal, Pannu, Young) elected with over 878K 'For' votes each.","Amendment to 2019 Omnibus Incentive Plan increasing share pool by 500,000 shares approved (779,164 for, 176,802 against).","Ratification of BD & Company as independent auditor for 2024 passed with 1,490,908 for, 32,346 against.","Advisory vote on executive compensation approved with 804,087 for, 164,034 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-025884","json":"https://secwatch.observer/filing/0001493152-24-025884.json","markdown":"https://secwatch.observer/filing/0001493152-24-025884.md","text":"https://secwatch.observer/filing/0001493152-24-025884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224025884/0001493152-24-025884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224025884/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:45:51.092141+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}